• About
  • Advertise
  • Careers
Sunday, November 22, 2026
Maritime Gateway
Advertisement
  • Home
  • Shipping
    • NVOCC
    • Tankers
  • Cargo
    • Air Cargo
    • Container Cargo
    • Dry Bulk
    • Liquid Bulk
    • LNG
    • Project Cargo
  • Global News
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
  • Ports & Terminals
    • Bulk Ports
    • Container Terminals
    • Port & Terminal Equipment
  • Logistics
    • Freight Forwarding
    • Logistics Parks
    • Supply Chain
    • Warehousing
  • Transport & Multimodal
    • Multimodal Transport
    • Rail
    • Trucking
    • Inland Waterways
  • Insights
    • Magazines
    • Interviews
    • Reports
    • Newsletters
    • Webinars
No Result
View All Result
  • Home
  • Shipping
    • NVOCC
    • Tankers
  • Cargo
    • Air Cargo
    • Container Cargo
    • Dry Bulk
    • Liquid Bulk
    • LNG
    • Project Cargo
  • Global News
    • Africa
    • Americas
    • Asia
    • Europe
    • Middle East
  • Ports & Terminals
    • Bulk Ports
    • Container Terminals
    • Port & Terminal Equipment
  • Logistics
    • Freight Forwarding
    • Logistics Parks
    • Supply Chain
    • Warehousing
  • Transport & Multimodal
    • Multimodal Transport
    • Rail
    • Trucking
    • Inland Waterways
  • Insights
    • Magazines
    • Interviews
    • Reports
    • Newsletters
    • Webinars
No Result
View All Result
Maritime Gateway
No Result
View All Result
Home
News

Indian pharma industry: Backbone of Indian economy

by Maritimegateway
November 23, 2020
in News
Reading Time: 3 mins read
A A

Warning: Trying to access array offset on false in /home/u380631772/domains/thebestfirms.com/public_html/wp-content/themes/jnews/class/Image/ImageNormalLoad.php on line 70

Warning: Trying to access array offset on false in /home/u380631772/domains/thebestfirms.com/public_html/wp-content/themes/jnews/class/Image/ImageNormalLoad.php on line 73

November 23, 2020: In the current pandemic (COVID-19) where India’s GDP has shrunk by 23.9 per cent in Q1 of the current fiscal, some of the sectors keeping the country alive is healthcare and pharma besides agriculture. The Indian pharma industry is known as ‘the pharmacy of the world’ as it is a leading supplier in generics with one of the highest numbers of USFDA approved plants. According to IKON Marketing Consultants’s estimates, in the current fiscal, 2020-21 the Indian pharma industry is estimated to be worth $43 billion.

Let’s have a look at how it is contributing during the current pandemic towards the health of our economy and check its pulse on different parameters.

The contribution to GDP and FDI inflow

In the last fiscal itself, the sector contributed around 1.72 per cent to the country’s GDP, making a significant mark. It was around one per cent a decade ago. A lot of research & development, government initiatives and FDI inflows opened newer avenues for the industry to grow further. There were around $ 16.5 billion FDI inflows during April 2000-June 2020, as 100 per cent FDI is allowed in greenfield projects under automatic route and 74 per cent FDI is allowed for brownfield projects under the automatic route. Still, there is an investment opportunity of $366.31 million in the pharma segment alone for almost 18 projects of different nature in different states await investors.

The major pillar: Exports

In the case of exports, drugs and pharma products have recorded positive growth of 24.89 per cent during September 2020 vis-à-vis September 2019 amongst a few other commodity groups. The export of pharma stood at $ 7,595 million and it remains the second-highest contributor with 7.79 per cent of total exports during April – Aug 2020, the 1st first being minerals with 8.94 per cent.

RelatedPosts

New post style guide

Paradip Port Targets 170 MMT Cargo as PPA Reviews Infrastructure and Operational Efficiency

Edgistify Adds 68,000 Sq Ft Warehouse at IndoSpace Luhari to Expand Gurugram Network

National Strategic Trade Command Centre Opens to Strengthen India’s Export Oversight

Tackling the current pandemic

The efforts of pharma companies to combat the current crisis with the help of the government shows the robustness of the industry itself. India is a hub and the largest manufacturer of vaccines in the world, the fight against COVID-19 cannot succeed without Indian vaccine manufacturers. India is also pioneering the discovery of COVID-19 vaccines and currently, a few of them are undergoing human trials. The times ahead would witness India at the forefront of the immunization drive against COVID-19.

The path towards becoming aatmanirbhar

To reduce the industry’s dependency on raw materials import, in March itself, the Indian government made a significant announcement of a package of Rs 14,000 crores to boost the domestic production of active pharma ingredients (APIs) and various medical devices. GoI is planning to set up mega bulk drug parks and also aims to make India a major hub for end-to-end drug discovery.

The road ahead

The current industry trends suggest that post-crisis, the Indian pharma industry will have improved storage and supply chain infrastructure and witness increased usage of digital media to market the drugs as well as to reach out to the prescribers and patients. Not just the urban markets, but pharma companies will increase their spending to develop better medical infrastructure to tap the rural markets as well. It is also expected that in the next decade, approx $200 billion will be spent on the medical infrastructure of the country. With the NCD component in India set to match international ratios, Indian companies are poised to bring down the cost of chronic therapy treatments worldwide. The Indian pharma industry will be one of the key drivers of growth in the country’s attempt to reach a five trillion dollar economy by 2024.

By all these means, not just during the current crisis, but in future too, the Indian pharma industry will prove to be the backbone of our economy and will work towards making India healthy and an ‘Aatmanirbhar’ country in the true sense.

Source: Express Pharma

Previous Post

Sri Lankan president says to further promote Belt and Road construction with China

Next Post

Petrobras hunts for oil buyers in India

Maritimegateway

The Maritime Gateway Editorial Team delivers trusted news, analysis, and insights on shipping, ports, logistics, supply chains, and global trade, backed by industry expertise and editorial review.

Next Post

Petrobras hunts for oil buyers in India

Follow Maritime gateway

    Popular News

    New post style guide

    New post style guide

    October 27, 2026
    Paradip Port Targets 170 MMT Cargo

    Paradip Port Targets 170 MMT Cargo as PPA Reviews Infrastructure and Operational Efficiency

    October 16, 2026

    Dirty fuels stage a comeback as emissions targets loom

    June 3, 2021
    Paradip Port Cargo Handling Push Targets Over 170 Million Tonnes in FY27

    Paradip Port Cargo Handling Push Targets Over 170 Million Tonnes in FY27

    October 16, 2026

    Business

    No Content Available

    recent

    New post style guide

    New post style guide

    October 27, 2026
    Paradip Port Targets 170 MMT Cargo

    Paradip Port Targets 170 MMT Cargo as PPA Reviews Infrastructure and Operational Efficiency

    October 16, 2026
    Edgistify Adds 68,000 Sq Ft Warehouse

    Edgistify Adds 68,000 Sq Ft Warehouse at IndoSpace Luhari to Expand Gurugram Network

    October 16, 2026
    National Strategic Trade Command Centre Opens

    National Strategic Trade Command Centre Opens to Strengthen India’s Export Oversight

    October 16, 2026
    India’s Merchandise Exports Rise 23%

    India’s Merchandise Exports Rise 23% as First-Half Earnings Reach $259.89 Billion

    October 16, 2026

    Latest Shipping and logistics news covering marine, Ports, Shipping, Logistics, containers, dry bulk & tankers that drive South Asian maritime Industry.

    Site Links

    • Interviews
    • News
    • Government
    • Shipping
    • Cargo News

    Site Links

    • Interviews
    • News
    • Government
    • Shipping
    • Cargo News

    Follow Us

    © 2026 – Powered by .

    • Terms of Use
    • Privacy Policy
    • Manage Cookies
    • License
    No Result
    View All Result
    • Home

    © 2026 JNews - Premium WordPress news & magazine theme by Jegtheme.